Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 4/20 | 0.41 |
| ▸ | NMUR2 | Q9GZQ4 | 6/20 | 0.40 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 4/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7326543 | 0.93 | NMUR2 (0.41) | HRH1NMUR2NMUR1ADORA3ADORA2A | |
| SCHEMBL10378306 | 0.91 | ADORA3 (0.41) | HRH1NMUR2NMUR1ADORA3ADORA2A | |
| SCHEMBL10376958 | 0.81 | F2 (0.43) | ADORA3ADORA2AADORA2BADORA1F2 | |
| SCHEMBL7320110 | 0.77 | CTSD (0.50) | NMUR2NMUR1ADORA3ADORA2AADORA2B | |
| SCHEMBL10377187 | 0.75 | NMUR2 (0.50) | NMUR2NMUR1OPRD1 | |
| SCHEMBL7329810 | 0.75 | CTRB1 (0.43) | F2 | |
| SCHEMBL7331125 | 0.75 | CTSD (0.43) | NMUR2NMUR1KISS1RF2 | |
| SCHEMBL10376833 | 0.75 | NMUR2 (0.51) | NMUR2NMUR1KISS1RF2OPRD1 | |
| SCHEMBL7325544 | 0.70 | BACE1 (0.51) | — | |
| SCHEMBL7328124 | 0.68 | BACE1 (0.51) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1990000399-A1 | RETROVIRAL PROTEASE BINDING PEPTIDES | SMITHKLINE BECKMAN CORPORATION (US) | 1990-01-25 | — | — | WO | disclosed |